Last reviewed · How we verify
Placebo Normal Saline (NS)
Normal saline is an inert isotonic solution that serves as a physiological vehicle for drug delivery or fluid replacement with no active pharmacological mechanism.
Normal saline is an inert isotonic solution that serves as a physiological vehicle for drug delivery or fluid replacement with no active pharmacological mechanism. Used for Placebo control in clinical trials, Intravenous fluid replacement and hydration.
At a glance
| Generic name | Placebo Normal Saline (NS) |
|---|---|
| Also known as | Sodium chloride, NS |
| Sponsor | The Miriam Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Normal saline (0.9% sodium chloride in water) is a non-medicated solution that matches the osmolarity of blood plasma, making it suitable for intravenous administration, wound irrigation, or as a control comparator in clinical trials. When used as a placebo, it provides no therapeutic effect beyond the vehicle itself and serves as a control to assess the true efficacy of an active comparator drug.
Approved indications
- Placebo control in clinical trials
- Intravenous fluid replacement and hydration
Common side effects
- Hypernatremia (with excessive administration)
- Fluid overload (with excessive administration)
- Injection site reactions (rare)
Key clinical trials
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) (PHASE1)
- Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults (PHASE2)
- Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy (NA)
- Parenteral Ascorbic Acid Repletion in TransplantatIon (PHASE4)
- Dexmedetomidine on Brain Injury Patients (NA)
- Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine (PHASE1)
- Botulinum Toxin-A for Hidradenitis Suppurativa (PHASE4)
- Dupilumab Therapy in Nephrotic Syndrome in Children (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |